These data suggest that post-translational modifications did not seem to be crucial for NC1 α4(IV) biological activity because the effects of the recombinant protein expressed in E. coli were similar to those obtained by NC1 α4(IV) overexpression in melanoma cells. The gene discussed is COL18A1; the disease is melanoma.